Modulation of drug metabolism in infectious and inflammatory diseases

被引:59
作者
Iber, H [1 ]
Sewer, MB [1 ]
Barclay, TB [1 ]
Mitchell, SR [1 ]
Li, T [1 ]
Morgan, ET [1 ]
机构
[1] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA
关键词
D O I
10.1081/DMR-100101906
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:29 / 41
页数:13
相关论文
共 41 条
[1]  
BILLIAR TR, 1992, ARCH SURG-CHICAGO, V127, P31
[2]  
Carlson TJ, 1996, MOL PHARMACOL, V49, P796
[3]  
CHEN J, 1994, J CELL BIOCHEM, V18, pO203
[4]  
DAVIS JF, 1993, J BIOL CHEM, V268, P16584
[5]   The PPAR alpha-leukotriene B-4 pathway to inflammation control [J].
Devchand, PR ;
Keller, H ;
Peters, JM ;
Vazquez, M ;
Gonzalez, FJ ;
Wahli, W .
NATURE, 1996, 384 (6604) :39-43
[6]  
Donato MT, 1997, J PHARMACOL EXP THER, V281, P484
[7]  
GELLER DA, 1994, ARCH SURG-CHICAGO, V129, P165
[8]  
GONZALEZ FJ, 1991, PROG CLIN BIOL RES, V372, P11
[9]   STRUCTURAL AND METABOLIC REQUIREMENTS FOR ACTIVATORS OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR [J].
GOTTLICHER, M ;
DEMOZ, A ;
SVENSSON, D ;
TOLLET, P ;
BERGE, RK ;
GUSTAFSSON, JA .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (12) :2177-2184
[10]   PPAR: A mediator of peroxisome proliferator action [J].
Green, S .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1995, 333 (1-2) :101-109